Publication
Published on: July 15, 2024
Published in: Frontiers in Pharmacology
Proceedings from: Joint Task Force for Clinical Trial Competency Biannual Global Meeting on June 6, 2024
Held at: Virtual Meeting
Published on: June 24, 2024
Published in: Cancer
Description: Sylvia Baedorf Kassis and Barbara E. Bierer were co-authors on a paper published in “Cancer” entitled “Acupuncture for hot flashes in hormone receptor‐positive breast cancer: A pooled analysis of individual patient data from parallel randomized trials.” The MRCT Center helped advise the study teams in the coordination and conduct of multi-national, collaborative research.
Comments provided on: September 5, 2023
Comments provided to: US Food & Drug Administration
The MRCT Center submitted comments in response to the FDA/ICH E6(R3) Guideline for Good Clinical Practice; International Council for Harmonisation; Draft Guideline for Industry (FDA-2023-D-1955-0002). The MRCT Center applauds the overall structural redesign of the E6(R3) GCP guideline and enthusiastically supports the proposed changes. Our comments identified specific areas that we believe, with revision and improvement, will further protect the rights, safety and well-being of all trial participants.
Released on: May 2022
Developed by: MRCT Center in collaboration with Dana-Farber/Harvard Cancer Center

Released on: June 2022
Developed by: MRCT Center Health Literacy Team
